Planta Med 2012; 78(09): 896-898
DOI: 10.1055/s-0031-1298486
Biological and Pharmacological Activity
Georg Thieme Verlag KG Stuttgart · New York

Inhibitory Effect of β-Sitosterol on TNBS-Induced Colitis in Mice

In-Ah Lee
1   Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Korea
2   Department of Pharmacy, Kyung Hee University, Seoul, Korea
Eun-Jin Kim
1   Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Korea
Dong-Hyun Kim
1   Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Korea
2   Department of Pharmacy, Kyung Hee University, Seoul, Korea
› Author Affiliations
Further Information

Publication History

received 16 January 2012
revised 14 March 2012

accepted 09 April 2012

Publication Date:
26 April 2012 (online)


β-Sitosterol, a common sterol in herbal medicines, exhibits anti-inflammatory effects beneficial in the treatment of lung inflammation, asthma, and bronchospasm. To evaluate whether β-sitosterol also has anticolitic benefits, we tested the effect of β-sitosterol on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice. β-Sitosterol inhibited colon shortening and led to lowered macroscopic scores and myeloperoxidase activity in TNBS-treated colitic mice. β-Sitosterol also inhibited the expression of proinflammatory cytokines TNF-α, IL-1β, and IL-6, and an inflammatory enzyme, cyclooxygenase (COX)-2, in the colons of TNBS-induced colitic mice, as well as the activation of NF-κB. Based on these findings, β-sitosterol may ameliorate colitis by inhibiting the NF-κB pathway.

Supporting Information

  • References

  • 1 Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004; 52: 463-479
  • 2 Benno P, Leijonmarck CE, Monsén U, Uribe A, Midtvedt T. Functional alterations of the microflora in patients with ulcerative colitis. Scand J Gastroenterol 1993; 28: 839-844
  • 3 Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon 2003; 1: 125-136
  • 4 Roscher R, Oettinger W, Beger HG. Bacterial microflora, endogenous endotoxin, and prostaglandins in small bowel obstruction. Am J Surg 1988; 155: 348-355
  • 5 Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune respone. Nature 2000; 406: 782-787
  • 6 Medzhitov R, Janeway Jr. C. Innate immunity. N Engl J Med 2000; 343: 338-344
  • 7 Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009; 136: 1182-1197
  • 8 Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010; 211: 361-370
  • 9 Rudkowska I. Plant sterols and stanols for healthy ageing. Maturitas 2010; 66: 158-162
  • 10 Yuk JE, Woo JS, Yun CY, Lee JS, Kim JH, Song GY, Yang EJ, Hur IK, Kim IS. Effects of lactose-beta-sitosterol and beta-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice. Int Immunopharmacol 2007; 7: 1517-1527
  • 11 Navarro A, De las Heras B, Villar A. Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens. Clem. Biol Pharm Bull 2001; 24: 470-473
  • 12 Mahajan SG, Mehta AA. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma. Eur J Pharmacol 2011; 650: 458-464
  • 13 Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000; 19: 51-62
  • 14 Cameron EA, Binnie JA, Balan K, Skerratt SA, Swift A, Solanki C, Middleton SJ. Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis. Scand J Gastroenterol 2003; 38: 535-537
  • 15 Matsuda K, Watanabe T, Abo Y, Uchida H, Kawamura YJ, Masaki T, Muto T. Severe complications of ulcerative colitis after high-dose prednisolone and azathioprine treatment. J Gastroenterol 1999; 34: 390-394
  • 16 Valerio M, Awad AB. β-Sitosterol down-regulates some pro-inflammatory signal transduction pathways by increasing the activity of tyrosine phosphatase SHP-1 in J774A.1 murine macrophages. Int Immunopharmacol 2011; 11: 1012-1017
  • 17 Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol 2011; 82: 278-286